Investment Pitches

Pitch Summary:
We are very excited about our investment in Basic Fit today. Basic Fit is the largest owner of low cost gyms (similar to Planet Fitness in the US) in Europe. Basic Fit has an absolutely dominant position in the space, with over 1,600 gyms in France, Spain, the Netherlands, Belgium, Luxembourg, and Germany. Basic Fit is larger than all of its smaller competitors combined. At maturity, a Basic Fit gym earns 30%+ ROIC and in some geographies over a 40% EBITDA margin. This is truly a dominant and very well positioned business. Basic Fit is well positioned in this macroeconomic environment, with little to no exposures to tariffs. We also believe that Europe is likely to have significant fiscal expansion to support its economies, and so as a region, we are bullish on Europe. This is showing in Basic Fit's data, with a very strong start to 2025 in their important January and February joiner season. We believe they have turned the corner and have several strong years ahead of them, and as they begin to beat investor expectations, the stock should rerate significantly. Recently, Basic Fit decided to invest in opening up its gyms in France 24 hours a day, 7 days a week. This investment cost them 35m euros, which surprised the market in March because they guided below consensus expectations for 2025. We believe strongly in this investment, for a few reasons. Firstly, the entire 35m euro cost is additional staffing, which we believe will only be temporary in nature. There is a French law prohibiting gyms from being run staffless overnight, and this is currently being litigated in the court system, and we believe the law now has a good chance of being overturned. If that were to happen, Basic Fit would get all the benefit of their gyms being open 24/7 and the entire 35m euro cost goes away. In a less optimal but still positive outcome, Basic Fit can roughly halve their staffing cost by switching from contractors to full time employees. They are employing more expensive contractors today because they believe they will ultimately be able to run these gyms without staff, and it is difficult to terminate full time employees in France. They do not want that liability if they are able to go without staff. So they are temporarily using higher cost contractors until they get clarity on whether they will be able to run them without staff. What this means in practical terms is that 2026 consensus numbers are far too low. Consensus EBITDA assumes the 35m euro investment stays forever, which will not be the case. This leads to significantly lower FCF/share expectations for 2026. We think the stock is worth north of 50 euros per share today and that they have set themselves up to start beating and raising vs. expectations, which should get the stock going in the right direction. Historically, they traded at 15-30x FCF and 9-13x EBITDA, which would lead to prices 200%+ higher just on today's numbers, and the business is still growing double digits.

BSD Analysis:
Buckley Capital presents an enthusiastic bull case for Basic-Fit as Europe's dominant low-cost fitness operator with significant operational leverage and misunderstood near-term investments. The manager emphasizes the company's market-leading position with over 1,600 gyms across six European countries, generating exceptional unit economics with 30%+ ROIC and up to 40% EBITDA margins at maturity. The investment thesis hinges on a temporary margin compression from a €35 million investment in 24/7 operations in France, which Buckley views as strategically sound but misunderstood by consensus. The manager expects this cost to be eliminated or significantly reduced through either regulatory changes allowing unstaffed operations or cost optimization through employment structure changes. Buckley believes 2026 consensus estimates are too conservative, failing to account for the temporary nature of these costs and the strong operational momentum evidenced by robust January-February membership growth. With historical trading multiples of 15-30x FCF and 9-13x EBITDA, the manager sees potential for 200%+ upside from current levels, setting a €50+ price target while the business continues double-digit growth.

Pitch Summary:
Dentalcorp is a business we have owned for over two years now. Dentalcorp will nearly double its free cash flow per share from 2022, when we first invested, through the end of 2025. Dentalcorp is the largest owner of dentist offices in Canada. We were attracted to the model because of the consistency of dental practices through a variety of economic environments. We also like Dentalcorp because it has less leverage than all of its private equity owned peers, while at the same time also outgrowing all of its competitors in Canada. Dentalcorp is the acquirer of choice for independent dentist practice owners, having acquired the largest number of practices in Canada. Dentalcorp also has a 90% partner dentist retention rate since inception in 2011. Dentalcorp has 1,850+ dentists, 2,600+ hygienists, and 5,750+ auxiliary dental health professionals across Canada. The average age of partner dentists is in their early 40s at the time of acquisition, allowing for continued growth within the practice. Partnering with Dentalcorp allows dentists to focus on what they love - their team and their patients - instead of having to worry about managing a business. Dentalcorp has a cash-pay model. Most patients pay directly at the time of service, and then either the patient or Dentalcorp submits a claim to the insurance company, and then the patient gets reimbursed. This gives the business neutral to negative working capital, with limited exposure to insurance companies or government pay. Dentalcorp has a 4%+ medium term target for same practice revenue growth. They also expect to average 30-35m of annual acquired PF adjusted EBITDA, which they have done since 2018. The synergies when acquiring a practice are a 10-15% increase in practice level EBITDA margin immediately following acquisition as well as visit frequency increases of 10-15% post-acquisition. The revenue synergies are driven by an expansion of specialty service offerings following acquisition. The cost synergies are driven by better labor management, national vendor procurement with preferred supplier pricing, and a tech enabled platform driving financial efficiencies. We also like DNTL because it is rare to be able to acquire a business with acyclical revenues and profits with a large addressable market where they are the market leader, have little competition, and trades at less than 10x FCF. Typically, businesses of this nature trade at over 20x FCF.

BSD Analysis:
Buckley Capital presents a compelling bull case for Dentalcorp as a defensive, cash-generative consolidator in the fragmented Canadian dental market. The manager highlights the company's dominant market position as Canada's largest dental practice owner with over 1,850 dentists and strong competitive moats including high dentist retention rates (90%) and proven acquisition synergies. The investment thesis centers on Dentalcorp's recession-resistant business model with acyclical revenues, negative working capital from cash-pay operations, and limited exposure to insurance reimbursement risks. Key financial metrics support the bullish stance, with management targeting 4%+ same-practice revenue growth and 30-35 million in annual acquired EBITDA, while delivering 10-15% EBITDA margin improvements and visit frequency increases post-acquisition. The valuation appears attractive at less than 10x free cash flow compared to typical 20x+ multiples for similar defensive businesses. Buckley expects free cash flow per share to nearly double from 2022 to 2025, making this a core holding positioned for steady growth regardless of economic conditions.

Pitch Summary:
We believe Virtus Investment Partners offers a compelling investment from current levels. Virtus Investment Partners is a multi-boutique traditional investment manager. The company has several investment affiliates with their own investment teams and strategies. Virtus provides centralized sales, middle- and back-office services to support these teams. Virtus has grown by using cash flow to acquire additional investment firms. It keeps the investment teams of the acquisitions in place and centralizes sales and operations. We successfully owned Virtus for the Fund several years ago. Our investment thesis is below: 1. High-Quality Business Due to Recurring Revenue and High Free Cash Flow - Virtus Investment Partners boasts a high-quality business model underpinned by recurring revenue streams and elevated free cash flow. The firm's strategic focus on asset management ensures steady income through management fees, which are largely predictable and stable. This recurring revenue is a testament to the company's robust client relationships and consistent performance, providing a strong foundation for continued growth. Furthermore, high free cash flow enables Virtus to reinvest in its business, pursue acquisitions, and return capital to shareholders, enhancing overall value. 2. Low Valuation on Price to Earnings and EV/EBITDA Basis - VRTS has an attractive valuation. It trades for 6.5x price-to-earnings (P/E) and a shockingly low 3.0x on Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization (EV/EBITDA) basis. VRTS has a strong balance sheet that matches the strong cash flow profile of the business. The company only has $100 million of net debt, which is about 0.3x EBITDA. In addition, VRTS carries a portfolio of seed investments in start-up funds and products valued at $140M. It recycles this seed capital into incubating new funds and products as existing seed investments payoff or fail. Virtus also has about $140M in CLO equity investments. These investments are made as its advisors form new CLOs. We subtract the seed investments and the CLO equity investments from Enterprise Value when we quote the 3.0x EV/EBITDA multiple. One could argue that seed investments and CLO equity investments are necessary to run the business. If we excluded these two items from Enterprise Value because they are necessary to run the business, we still calculate a very low 4.0x EV/EBITDA multiple. Virtus trades at a lower multiple compared to its peers 3. Low Debt Levels Provide Management Flexibility - The firm's prudent approach to debt management further strengthens its investment appeal. Virtus Investment Partners maintains low debt levels, which afford management significant flexibility to act on M&A or share repurchase opportunities. This conservative financial stance mitigates risk and enhances the firm's ability to sustain operations during economic downturns. 4. Potential for Earnings Accretive Acquisition - Virtus Investment Partners is well-positioned to pursue earnings accretive acquisitions. The firm's strong balance sheet and free cash flow provide the necessary capital to acquire additional investment management capabilities. Multiples for privately held investment management businesses are inexpensive. Virtus has a strong platform and history of integrating acquisitions to realize synergies and create value. 5. Consistent Dividends and Stock Repurchases – VRTS management has been consistent in returning capital to shareholders through dividends and stock repurchases. VRTS stock currently yields 5.6%. Stock repurchases further enhance shareholder value by reducing outstanding shares and increasing earnings per share (EPS). In Q1, VRTS management repurchased about 2% of the stock and signaled that they would be more aggressive given the stock price decline from early March. We would encourage management to consider increasing leverage by 1.0x EBITDA and repurchase 30% of the shares. There are risks to our investment thesis on Virtus: 1. Challenged Flows Due to Active Management Out of Favor - Despite its strengths, Virtus Investment Partners faces challenges in asset flows, primarily due to the growing trend towards passive management. Active management has fallen out of favor with some investors, who prefer the lower fees and perceived simplicity of passive strategies. This shift poses a headwind for Virtus, potentially impacting on its ability to attract and retain assets. The firm must navigate this evolving landscape by demonstrating the value of active management and differentiating its offerings through superior performance and client service. 2. Some Past Acquisitions May Not Have Paid Off - Virtus's acquisition strategy, while generally successful, has not been without its missteps. Some past acquisitions have not delivered the anticipated returns. These underperforming acquisitions can weigh on financial results and erode investor confidence. 3. Waiting for Flows to Improve or Management to Take Action - Virtus Investment Partners is at a crossroads, awaiting improvement in asset flows or action from management to make an acquisition or materially increase share repurchases. This state of waiting creates uncertainty and requires patience from investors. In summary, Virtus Investment Partners presents a compelling investment case with a robust business model, attractive valuation, low debt levels, and a clear commitment to shareholder returns. However, the firm must navigate challenges related to asset flows and past acquisitions. Investors should weigh these strengths and weaknesses carefully, considering Virtus's potential for growth and the strategic actions needed to address its current hurdles. With prudent management and strategic execution, Virtus Investment Partners could deliver substantial value to its shareholders over the long term.

BSD Analysis:
Gator Capital presents a compelling value thesis on Virtus Investment Partners, emphasizing the company's multi-boutique asset management model with centralized operations. The manager highlights VRTS's exceptionally attractive valuation at 6.5x P/E and 3.0x EV/EBITDA, significantly below peer multiples, supported by strong free cash flow generation and minimal leverage at 0.3x EBITDA. The investment case centers on the company's recurring revenue model from management fees, providing predictable cash flows that enable strategic acquisitions and shareholder returns through a 5.6% dividend yield and aggressive share repurchases. Management's capital allocation flexibility is enhanced by the conservative balance sheet, positioning VRTS to pursue accretive M&A opportunities in a favorable acquisition environment for private investment managers. However, the manager acknowledges meaningful headwinds including challenging asset flows due to the industry-wide shift toward passive management and mixed results from historical acquisitions. The thesis requires patience as investors await either organic flow improvement or more aggressive capital deployment by management. Despite these challenges, the combination of deep value pricing, strong fundamentals, and potential catalysts from increased share buybacks or strategic acquisitions creates an asymmetric risk-reward profile for patient value investors.

Pitch Summary:
TerraVest is a metal manufacturer of critical products in North America's fuel infrastructure markets. We believe TerraVest is a high-quality compounder, led by a capable management team with a solid track record of execution. We think this volatile market environment creates more M&A opportunities for TerraVest as a serial acquirer of manufacturing businesses.

BSD Analysis:
The managers view TerraVest as a high-quality compounder with strong execution capabilities in North America's fuel infrastructure markets. They highlight the company's capable management team and solid track record as key investment drivers. The thesis centers on TerraVest's role as a serial acquirer, with the current volatile market environment potentially creating more attractive M&A opportunities for the company. The managers believe the company's manufacturing focus on critical fuel infrastructure products provides a defensive moat. TerraVest was identified as one of the top three contributors to fund performance during Q1 2025. The investment appears to benefit from both organic growth potential and inorganic expansion through strategic acquisitions. The managers maintain confidence in the company's ability to compound returns through disciplined capital allocation.

Pitch Summary:
@marginofdanger argues that the newly announced transaction for $HHH, although not his preferred outcome, is ultimately beneficial for shareholders. The deal introduces a 38 bps management fee and a 1.5% performance fee while layering in a sizable $900M equity raise at $100/share, which he estimates is roughly $5 per share accretive relative to the prior trading price. Before Ackman’s involvement, $HHH traded at ~50% of NAV because the market struggled with underwriting a CRE/land-bank hybrid that offered little clarity around capital returns. He notes that long-term holders saw theoretical value, but the discount persisted due to structural skepticism. With Ackman taking control, he expects the shareholder base to shift toward investors who understand and appreciate the long-duration nature of the assets. He believes Ackman’s visibility and following will help rerate the stock given the small float and the company’s lack of prior promotional energy. Although governance changes and incentive fees are not costless, he expects Ackman to have tools to close the NAV discount. Overall, he views the transaction as a cautious but meaningful positive.

BSD Analysis:
Howard Hughes has long suffered from the market’s inability to value land-bank-heavy real estate structures, where monetization is lumpy and capital allocation is critical. The introduction of Ackman as an aligned external manager may help impose clearer return frameworks and narrative discipline—something HHH has historically lacked. The accretive equity raise strengthens the balance sheet and potentially accelerates development timelines, which could raise NAV realization multiples as projects move from conceptual to income-producing. However, external management structures typically create valuation overhangs due to fee leakage, so the long-term effect will depend on Ackman’s ability to create tangible returns that exceed those fees. Strategically, Ackman’s brand and investor audience could attract a shareholder base more tolerant of multi-year monetization pathways, reducing the discount rate implicit in HHH’s valuation. The key risk remains the cyclical nature of commercial real estate and the long horizons required to unlock value across master-planned communities. Execution on capital recycling and transparent reporting will determine whether the market begins to close the NAV gap. In essence, the transaction raises both the floor (via capital and attention) and the stakes (via incentive fees), but on balance should create a more credible path to narrowing the discount to intrinsic value.

Actual Post Content:
$HHH While I would have preferred no transaction, I think the transaction announced today is a nice positive for shareholders - it amounts to layering in a management fee of 38bps/year and a 1.5% performance fee. Plus, the primary equity raise ($900mm at $100/share) is ~$5/share of accretion vs. where the stock was trading. Absent Ackman, $HHH was trading at around ~50% of its NAV, reflecting the market's difficulty of underwriting and having the patience for effectively a CRE/land bank hybrid without any real promise of a return of capital. For those long-term oriented, the returns seemed good but theoretical. With Ackman, we are now going to see some changes in the shareholder base, but I believe net/net the changes to the shareholder base should be a positive as Ackman has a large audience and the float here is relatively small. Having a public company is his life's dream and I'm sure he truly has good ways to enhance the value of the company and close the discount to NAV. Time will tell but for now I am cautiously supportive.

URL: https://x.com/marginofdanger/status/1919388102189351244

Pitch Summary:
CEE lets you buy a diversified Poland/Hungary equity basket roughly at NAV while getting a large portfolio of Russian blue chips for free. Pre-war, ~70% of the fund was in Russia; those positions remain but are carried at zero, while the fund now holds ~$90m of non-Russian names led by Polish/Hungarian financials and Orlen. At today’s price CEE trades near ex-Russia NAV, yet MOEX marks imply Russian holdings worth >50% of NAV. Marking those at current local prices and applying a normal 14% CEF discount yields $18.70 per share (~28% upside). Upside could be higher from escrowed “Type C” dividends (~$2.50/sh), potential rerating of Russian equities, ruble normalization, and a structure fix from Bulldog Investors. The current portfolio ex-Russia is concentrated but largely blue-chip and dividend-paying, limiting idiosyncratic risk. The Russian sleeve concentrates in Lukoil, Sberbank, Gazprom, Magnit, and Polyus—world-scale assets priced at trough multiples domestically. A full peace is not required—any incremental sanction relief could unlock partial value and narrow the discount. Base case is a Graham-style discounted dollar with catalysts over 12–24 months. Risk is mainly geopolitical: extended war, harsher sanctions, or asset sequestration.

BSD Analysis:
A DWS-managed closed-end fund focused on Central & Eastern Europe; ex-Russia book is ~70% Poland and ~20% Hungary, heavy in financials and energy. Set-up: Russian positions written to zero for NAV despite ongoing MOEX trading; shares now trade near ex-Russia NAV, embedding a free option on Russian recovery. Thesis: Re-mark Russian holdings to local prices and apply a normalized CEF discount → ~28% upside; additional optionality from escrowed dividends, FX mean reversion, and potential activist-driven structure changes. Valuation: Historic CEE discounts run mid-teens; applying 14% to a re-struck NAV is conservative relative to potential activism-induced narrowing. Catalysts: Peace-talk progress, partial sanction relief (dividends/capital mobility), Bulldog activism (tender/ETF conversion), and improving sentiment to CE3 equities. Risks: Prolonged conflict or expropriation, permanent sanctioning of distributions, deterioration in Polish/Hungarian macros, and headline risk around Russia exposure; however, ex-Russia book quality anchors downside.

Pitch Summary:
Olympus is the global leader in GI endoscopy with ~70% share worldwide (~90% in the U.S.), anchored by its EVIS X1 platform and a 5–7 year replacement cycle. The firm has exited legacy low-margin imaging/scientific units and is now a focused med-tech operator with improving discipline on SG&A and customer-centric org design. Near-term optics are clouded by China’s anti-corruption clampdown and 2024 CEO turmoil, but governance has been reset and the chairman has reassumed the helm during the CEO search. Single-use endoscopes are growing, but penetration in core GI (colonoscopy/gastroscopy) remains minimal and economics favor reusable systems at scale; Olympus offers single-use where it makes sense (e.g., bronchoscope/ureteroscope) and has a China partner to compete on cost. EVIS X1 U.S. roll-out plus installed-base refresh in developed markets should underpin mid-single-digit constant-currency growth, with emerging markets (very low endoscopist density) as a long runway. GIS (GI) carries mid-20s EBIT margins and ~2/3 of revenue/EBIT, while SIS (urology/respiratory/other) improves toward ~20% EBIT with mix and cost work. Corporate overhead is stepping down (¥45B → ¥35B by FY26), creating operating leverage into the refresh. Balance sheet is near net-cash and buybacks continue (share count down ~15% since 2018). On ~12x FY25 EV/EBIT, with a path to ~20% group EBIT by FY26/27, the risk/reward looks attractive versus med-tech peers that trade in the high-teens to 20s.

BSD Analysis:
Olympus is a pure-play endoscopy/med-tech company after shedding cameras/scientific, with dominance in GI and strong positions in pulmonology/urology. Set-up: Stock is discounted by legacy governance baggage, a 2024 CEO incident, China demand softness, and investor debate over single-use disruption. Numbers: FY25 guide implies low-teens EV/EBIT and mid-teens P/FCF with net debt ≈ zero; management targets ~20% EBIT as GIS sustains mid-20s and SIS lifts, while HQ costs fall by ~¥10B from FY24 to FY26. Product cycle: EVIS X1 is early in a global replacement wave (U.S. launched recently) that historically drives multi-year order books and service annuities. Debate: Single-use will keep gaining in niches (bronchoscopy, cholangio, uretero), but GI mass-volume economics, physician training, and capital contracts favor reusable ecosystems; Olympus also fields its own single-use SKUs and a China manufacturing partner (Vathin). Risks: Prolonged China reimbursement/procurement reforms, additional FDA quality actions, slower SIS margin lift, or accelerated single-use adoption in GI. Variant view: Market underestimates durability of GI moats and the operating-leverage from HQ/SG&A cuts into a replacement upcycle; a re-rating toward peer EV/EBIT (≥15x) on 20% EBIT power offers meaningful upside.

Pitch Summary:
The Joint Corp. is transitioning from a hybrid owner/franchisor to a pure franchise model by selling its 125 company-owned chiropractic clinics, which should unlock significant margin and FCF leverage. Post-restructuring, JYNT will have roughly 950 franchise locations, net cash exceeding $50–60M, and minimal capex needs. CEO Sanjiv Razdan (ex-YUM!) and major shareholder Jeff Graham are driving the shift toward efficiency, lower G&A, and stronger franchisee relations after years of poor execution under prior management. The refranchising could generate ~$30M proceeds, and together with $25M of existing cash, 1/3 of the market cap will be in cash. Corporate overhead cuts of ~$5M could raise EBITDA to ~$15M and FCF to ~$12M, implying a sub-$100M EV and a low-teens FCF yield. Franchising economics remain compelling — ~$500K investment, ~$585K average sales, ~20% EBITDA margins — supporting steady unit growth. With a cleaner structure and 7–9% royalty stream, incremental margins should expand materially as new franchisees open. Management’s focus on digital marketing and franchise satisfaction can accelerate openings post-2025. A conservative 15× FCF multiple plus cash yields ~$15/sh (50% upside), with additional optionality from renewed growth.

BSD Analysis:
JYNT operates and franchises chiropractic clinics offering subscription-based, low-cost spinal adjustments (no insurance accepted). Thesis: The company is divesting owned units to become a high-margin, asset-light franchisor. Economics: After $30M refranchising proceeds, JYNT will sit on ~$60M net cash and generate $12M+ FCF on ~$15M EBITDA — a 12% yield at a sub-$100M EV. Management: New CEO Sanjiv Razdan, backed by majority holder Jeff Graham, is focused on cutting overhead and rebuilding franchise trust, reversing missteps by prior leadership. Growth: Unit openings slowed in 2024 due to restructuring but should reaccelerate from 2026, as economics (20%+ ROI for franchisees) and white-space opportunity remain strong. Risks: Recessionary same-store sales declines (-5–10%), chiropractor turnover, and patient churn could limit near-term performance; however, structural FCF strength and cash cushion create downside protection. Variant View: Market underestimates durability and scalability of a pure franchise model—this is a small-cap turnaround that could trade toward 20× FCF (~$20/share) as execution credibility builds.

Pitch Summary:
MSGS owns the Knicks and Rangers—trophy assets with private-market values far above public EV. The recent MSG Networks (RSN) reset cut local fees ~28%/19% for Knicks/Rangers, but local is ~15% of revenue and national media is the real engine. The NBA’s new 11-year, ~$76B deal (starts 2025–26) underpins team cash flows and values. Celtics’ ~$6.1B sale (despite limited arena/RSN economics) supports higher comps for blue-chip NBA franchises. Author marks combined Knicks+Rangers at ~$11–11.5B (Forbes/Sportico), implying ~$416/sh after net debt—>55% discount vs. ~$186. Ticket pricing power is material (reported ~17% STH increase for 25/26), helping offset RSN givebacks. Intrinsic value likely compounds regardless of macro, and scarcity keeps private buyers deep. Biggest knock is “no catalyst,” but time and continued league monetization should narrow the gap.

BSD Analysis:
Two iconic NYC franchises (NBA/NHL) with ancillary dev teams and esports. Setup/Thesis: Public price implies a deep discount to credible private marks (Forbes/Sportico; recent Celtics print) even after RSN fee reductions. Quality/Moat: Scarcity, market scale, national media tailwinds, brand power, and pricing leverage on tickets/partnerships. Numbers: Local media ≈15% of revenue; national deals and playoffs-driven upside matter more; debt ~$1.1B vs. multi-billion asset base. Risks: Dolan control and lack of sale catalyst; RSN ecosystem pressures; league CBA/cap shocks; on-court variance. Variant View: Street fixation on RSN drama overstates impact; STH repricing and national rights uplift plus trophy scarcity should drive steady NAV accretion and eventual re-rating.

Pitch Summary:
MGM offers investors exposure to a stable, cash-generating U.S. casino portfolio plus multiple “free call options” in digital gaming and international development. The domestic Las Vegas and regional operations generate roughly $1.5B of EBITDA and $1B in free cash flow annually—more than enough to justify MGM’s $8.4B ex-China enterprise value. Despite this, MGM shares trade lower than in 2022 even as share count is down 25% and FCF is up 20%. The core Vegas business has stabilized at post-COVID levels supported by strong visitation, sports tourism, and high-90s occupancy rates. MGM has been returning nearly all domestic FCF through buybacks, reducing shares from 486M in 2021 to 289M today (a ~16% FCF yield). Additional upside stems from BetMGM’s turnaround to profitability and $500M EBITDA potential, a rapidly scaling international digital platform via LeoVegas/Tipico acquisitions, and the Osaka, Japan project—expected to deliver $450–850M in MGM’s share of future EBITDA. At current prices, investors receive these three assets essentially for free. Domestic FCF durability is proven after four years of consistent results, and management is simplifying reporting to highlight cash generation. With catalysts across digital, Japan, and potential Entain consolidation, MGM could re-rate toward $50/share over the next few years.

BSD Analysis:
MGM operates nine Las Vegas resorts, seven regional U.S. casinos, 56% of MGM China, and expanding global digital and development projects. Core thesis: The ex-China domestic portfolio alone supports MGM’s valuation at <6× EBITDA and ~16% FCF yield, while investors get BetMGM, the international digital unit, and Japan optionality for free. Stability: Post-COVID volumes and wager data show structural Las Vegas growth driven by sports/events, not transient “revenge travel.” Capital allocation: 100% of FCF returned through buybacks; leverage only ~1× net of MGM China. Optionality: BetMGM’s re-acceleration (17%+ growth, $500M EBITDA target), international digital reaching $1B+ sales with double-digit margins, and Osaka’s 2H30 opening provide multiple paths to 50%+ upside. Risks: Consumer downturn, JV partner (Entain) friction, digital execution, or cost overruns in Japan; however, these are offset by strong recurring U.S. cash flow.

Pitch Summary:
CEE lets you buy a diversified Poland/Hungary equity basket roughly at NAV while getting a large portfolio of Russian blue chips for free. Pre-war, ~70% of the fund was in Russia; those positions remain but are carried at zero, while the fund now holds ~$90m of non-Russian names led by Polish/Hungarian financials and Orlen. At today’s price CEE trades near ex-Russia NAV, yet MOEX marks imply Russian holdings worth >50% of NAV. Marking those at current local prices and applying a normal 14% CEF discount yields $18.70 per share (~28% upside). Upside could be higher from escrowed “Type C” dividends (~$2.50/sh), potential rerating of Russian equities, ruble normalization, and a structure fix from Bulldog Investors. The current portfolio ex-Russia is concentrated but largely blue-chip and dividend-paying, limiting idiosyncratic risk. The Russian sleeve concentrates in Lukoil, Sberbank, Gazprom, Magnit, and Polyus—world-scale assets priced at trough multiples domestically. A full peace is not required—any incremental sanction relief could unlock partial value and narrow the discount. Base case is a Graham-style discounted dollar with catalysts over 12–24 months. Risk is mainly geopolitical: extended war, harsher sanctions, or asset sequestration.

BSD Analysis:
A DWS-managed closed-end fund focused on Central & Eastern Europe; ex-Russia book is ~70% Poland and ~20% Hungary, heavy in financials and energy. Set-up: Russian positions written to zero for NAV despite ongoing MOEX trading; shares now trade near ex-Russia NAV, embedding a free option on Russian recovery. Thesis: Re-mark Russian holdings to local prices and apply a normalized CEF discount → ~28% upside; additional optionality from escrowed dividends, FX mean reversion, and potential activist-driven structure changes. Valuation: Historic CEE discounts run mid-teens; applying 14% to a re-struck NAV is conservative relative to potential activism-induced narrowing. Catalysts: Peace-talk progress, partial sanction relief (dividends/capital mobility), Bulldog activism (tender/ETF conversion), and improving sentiment to CE3 equities. Risks: Prolonged conflict or expropriation, permanent sanctioning of distributions, deterioration in Polish/Hungarian macros, and headline risk around Russia exposure; however, ex-Russia book quality anchors downside.

Pitch Summary:
Genesis Energy is a midstream MLP positioned for a major re-rating following the $1.4B sale of its soda ash business to WE Soda. The sale removed cyclicality, eliminated ~$200M in annual cash costs, and de-levered the balance sheet by retiring revolver, notes, and preferred obligations. Pro forma 2026 EBITDA is expected around $660M, with maintenance capex slashed from $130M+ to ~$50M and free cash flow to equity rising to ~$2.50 per share (18% yield). Management plans to hike the distribution from $0.66 to $1.50 in 2025 and potentially to $2.00+ as preferreds are redeemed, targeting ~4× debt/EBITDA and high-teens FCF yield. Two new deepwater projects—Shenandoah and Salamanca—begin ramping mid-2025 and are contracted to add $110M in incremental EBITDA at 75% of base volumes. Upside exists if producers exceed contracted output or sanction further tiebacks like Monument, Phase 2, and Shenandoah South, which could extend throughput for years. The marine segment remains steady with structural tailwinds as barge capacity tightens and rates rise. At a $13.80 unit price, GEL trades at <9% of pro forma 2026 FCF yield versus peers near 6–7%, implying a path to double with dividend normalization. Management has emphasized deleveraging and capital returns, not growth spending, for the first time in years. On an 8% yield of a $2 dividend, units would be worth ~$25–$26 within two years.

BSD Analysis:
Genesis Energy operates offshore and onshore pipelines, a marine transportation fleet, and a sulfur services business; the recent soda ash divestiture exited its most cyclical and capex-heavy segment. Thesis: Post-sale, GEL becomes a streamlined, cash-flow-heavy midstream entity focused on deleveraging and returning capital through sharply higher distributions. Valuation: Trades at ~9% 2026 FCF yield versus peers near 6%, and the targeted $2 dividend implies an 8% yield and ~$25+ fair value. Execution: With Shenandoah and Salamanca contracted ramp-ups, minimal maintenance capex, and no major growth spending, execution risk is low. Optionality: Additional tiebacks (Monument, Shenandoah Phase 2, Shenandoah South) could lift EBITDA $25–$50M+ beyond base guidance, while a sale of the marine segment (~$900M valuation) or sulfur assets could accelerate deleveraging. Risks: Offshore timing slippage, marine rate volatility, or a capital allocation reversal could delay the dividend recovery, but the base case remains strongly cash-flow positive.

Pitch Summary:
Growth is slow, and competitors pose threats. Revenue at risk as tariff-sensitive customers collapse. Over 50% of e-commerce customers face insolvency due to tariffs and de minimis loophole closure.

BSD Analysis:
Klaviyo trades at high multiples as a marketing automation SaaS. Bears highlight slowing growth post-IPO, reliance on SMB e-commerce (esp. Shopify ecosystem), and competition from Mailchimp/HubSpot. With rising churn and CAC pressure, the path to durable free cash flow is uncertain.

Pitch Summary:
Key customers are insourcing and using competitors, with a 38% drop in purchases. The first earnings call in 32 years allegedly hid customer issues. Management sold $48M in stock since March 2024. AJR Enterprises' purchase is overpriced, stagnant, and reliant on one customer.

BSD Analysis:
UFP Technologies is a niche packaging supplier (esp. medical and protective). Bear cases point to customer concentration, cyclicality in industrial packaging, and stretched valuation. Rising resin/foam costs and supply chain issues could weigh on margins.

Pitch Summary:
98% government‐dependent revenue; chronic cost overruns & delays on government contracts; possible government IT contract cancellations.

BSD Analysis:
Booz Allen trades at a premium multiple as a government IT/defense consultant. Bear theses highlight reliance on cost-plus contracts, margin pressure from wage inflation, and potential regulatory scrutiny of billing practices. Slower federal budget growth or competitive contract re-bids could compress valuation.

Pitch Summary:
Wesdome is a small-cap Canadian gold producer positioned for strong earnings leverage to higher gold prices and production growth. The company operates two wholly owned underground mines—Eagle River in Ontario and Kiena in Quebec—both with adjacent underutilized processing facilities that enable low-cost volume expansion. After multi-year development, Kiena entered full production in 2024, and combined company output is expected to rise ~16% YoY to 190–210K ounces in 2025. At current gold prices above $3,200/oz (vs. $2,433 realized in 2024), Wesdome’s earnings could more than double to ~$1.34/share, putting it at <9× forward EPS. Management’s “Fill the Mill” plan blends high-grade underground and lower-grade open-pit ore to maximize throughput without diluting margins. All-in sustaining costs (AISC) are guided down to ~$1,400/oz, further expanding profitability. The pending $40M acquisition of Angus Gold consolidates 100,000 contiguous acres around Eagle River, improving exploration efficiency and reserve potential. The balance sheet is debt-free with ~$88M in cash, providing self-funding for exploration and growth. With additional output from Presqu’ile expected by late 2025, free cash flow could surge in tandem with earnings. The setup offers asymmetric upside in a favorable macro backdrop for gold, with operational risk mitigated by jurisdictional safety and experienced management.

BSD Analysis:
Wesdome operates two high-grade Canadian underground gold mines (Eagle River, Kiena) with long mine lives, mill capacity, and active exploration upside. Thesis: After years of reinvestment, 2025 marks a turning point—production up 15–20%, costs falling, and realized gold prices 30% higher YoY—driving a sharp earnings and FCF re-rate. Economics: 2025 guidance implies ~$400M+ revenue and ~$1.34 EPS (8.6× P/E) with AISC of ~$1,400/oz versus spot >$3,200/oz, supporting exceptional margins. Balance sheet: Net cash position (~$88M) and zero debt allow internally funded expansion and exploration, including the Angus Gold land consolidation. Growth: Presqu’ile shaft (late 2025) adds incremental 10K oz/year and enhances access to deeper high-grade zones. Risks: Sustained gold price weakness, operational disruptions, or grade volatility; however, political stability and excess processing capacity lower structural risk. Variant View: Market underappreciates Wesdome’s near-term production ramp, fixed-cost leverage, and clean balance sheet—setting up a rerating toward mid-teens P/E on cyclical peak cash flow.

Pitch Summary:
Texas Instruments, the world’s largest analog semiconductor producer, is nearing the end of a major capex build that will depress near-term FCF but set up a multiyear acceleration beginning in 2026. Over the past decade, TI pivoted toward industrial and automotive end markets—now 70% of sales—with long product cycles, high switching costs, and structurally higher margins. Despite cyclical sales declines across 2023–24, analog segment margins stayed in the high 30s–40s, underscoring exceptional business quality and ROIC durability. The company is reining in its four-year $5B/year investment plan after Elliott Associates’ 2024 campaign pushed for tighter capital discipline and a formal FCF/share target of $9+ by 2026. FCF conversion should rebound as fabs (Lehi, Sherman, Richardson) ramp and spending normalizes, with buybacks resuming—TI has reduced its share count 47% since 2004. Near-term, growth is returning: Q1 2025 sales rose 11% and guidance implies +9–19% YoY, with analog up 13%. The dividend yield (~3.3%) is well covered, and management only repurchases shares when trading below intrinsic DCF value. Valuation at ~16–17× normalized 2026 FCF offers a mid-teens annualized return potential with limited secular risk. Risks are macro-driven—recession or trade conflict—but TI’s domestic fabs and CHIPS Act incentives provide insulation. The setup offers both cyclical recovery upside and long-term compounding from one of the highest-quality franchises in semiconductors.

BSD Analysis:
TI designs and manufactures analog and embedded semiconductors used across industrial, automotive, and communications markets. Thesis: A durable high-margin analog leader, TI is transitioning from peak investment toward a FCF inflection starting 2026, catalyzed by Elliott’s push for capital returns. Economics: Analog’s 40%+ operating margins, 20%+ ROIC, and stable growth (mid/high single digits) justify premium valuation; 2026E FCF/share of $9–10 implies a ~6% yield at today’s price. Capital allocation: $5B capex cycle (2022–26) funded U.S.-based fabs with long-term CHIPS credits; buybacks and dividends (~100% of FCF payout) should normalize post-cycle. Trends: End-market mix (70% auto/industrial) supports secular growth; recovery already visible with double-digit analog rebound. Risks: Demand cyclicality, China exposure, and prolonged macro softness. Variant View: The market’s near-term capex fatigue overlooks a steep FCF ramp in 2026+, positioning TXN for sustainable double-digit TSR with inflation-protected yield and top-tier capital stewardship.

Pitch Summary:
Worthington Steel (WS) is a recent spinoff in steel processing. The company serves cyclical end markets like autos and construction, both of which have been under pressure over the last 6–9 months. Earnings have followed suit. While WS is not our typical high-quality compounder, it offers compelling attributes: strong customer relationships, exposure to secular growth areas like electrical steel, a near-debt-free balance sheet, and a culture of operational excellence. At current prices, we believe the shares offer attractive value, though we acknowledge the cyclical nature of the business and have sized the position accordingly.

BSD Analysis:
Springview acknowledges Worthington Steel as an atypical investment that deviates from their usual high-quality compounder strategy, but sees compelling value at current prices. The company operates in cyclical end markets including automotive and construction, both experiencing pressure over the past 6-9 months, which has weighed on earnings and share price. Despite the cyclical headwinds, the manager identifies several attractive attributes including strong customer relationships that provide competitive moats and pricing power. The company's exposure to secular growth areas like electrical steel offers long-term upside beyond traditional cyclical recovery. Worthington's near-debt-free balance sheet provides financial flexibility and reduces downside risk during cyclical downturns. The culture of operational excellence suggests management's ability to navigate challenging periods and optimize performance. The manager has appropriately sized the position to reflect the cyclical risks while capitalizing on what appears to be attractive valuation at current levels.

Pitch Summary:
Seaport Entertainment (SEG) owns a collection of real estate and entertainment assets in New York City and Las Vegas. We purchased the shares shortly after the company was spun off from Howard Hughes last July. The position contributed meaningfully in 2024. Little has changed in the underlying story to justify a >20% decline year-to-date—except investor impatience. Seaport's $160 million enterprise value is a small fraction of the >$1 billion invested in its assets by the former parent. New management has been tasked with monetizing non-core holdings and stabilizing core real estate. One asset alone—a full city block zoned for development in Lower Manhattan—might be worth the entire current market cap. A successful sale could serve as a near-term catalyst.

BSD Analysis:
Springview views Seaport Entertainment as a compelling value opportunity trading at a significant discount to underlying asset value. The company's $160 million enterprise value represents a fraction of the over $1 billion invested by former parent Howard Hughes, creating substantial embedded value. The manager believes the recent 20% decline reflects investor impatience rather than fundamental deterioration, presenting an attractive entry point. New management's strategy focuses on monetizing non-core assets and stabilizing core real estate operations, which should unlock value over time. The investment thesis is anchored by tangible real estate assets, including a full city block in Lower Manhattan zoned for development that alone could justify the entire market capitalization. This asset-heavy approach provides downside protection while offering multiple catalysts for value realization. The spinoff nature of the investment creates additional opportunity as the market may not fully appreciate the standalone value of the separated entity.

Pitch Summary:
Mercury General (MCY) is a midsized writer of personal auto and homeowners insurance, focused on the California market. We began purchasing shares in February 2024, believing the California personal lines market was entering a period of favorable pricing and regulatory support, setting the stage for a profitability inflection. We acquired shares around $50 and estimated normalized EPS in the range of $8.00–$10.00, supporting a fair value between $80–$120. On top of that, the centenarian founder could one day pursue a sale, potentially at a large premium. Our thesis played out in 2024, with MCY securing significant rate increases and delivering strong earnings—EPS annualized above $10/share in the final two quarters of the year. The stock rose roughly 50% from our cost basis and was a major contributor to 2024 performance. This year's underperformance stems from the Los Angeles wildfires that erupted on January 7 and devastated two urban neighborhoods. Although primarily an auto insurer, Mercury bundles homeowners' policies with auto coverage, which exposes it to property losses. While the company carries reinsurance, initial uncertainty around the scale of losses led to investor panic. For us, the critical question was whether this would be a capital event—requiring a dilutive capital raise—or an earnings event that would hit short-term profits but leave the long-term outlook intact. After extensive diligence—analyzing DOI and statutory filings, cross-checking Cal Fire data, reviewing reinsurance treaties, and studying precedent cases—we concluded that the losses were most likely an earnings event, not a capital event. We expect Mercury to report a sizable Q1 loss (earnings are due May 6), but we continue to estimate normalized EPS of ~$9.00 over the next few years. Ironically, the catastrophe may have improved the operating environment for insurers: with an estimated $45 billion in industry losses, capacity has tightened, pricing is rising, and California regulators have become more receptive to rate increases. We believe this should sustain a "hard" market in personal lines and reinforce our long-term earnings thesis. Investors today appear to be overweighting the recent catastrophe—a classic case of recency bias—while underestimating Mercury's capital strength and normalized profitability. In time, we believe attention will shift back to earnings and book value, both of which suggest substantial upside.

BSD Analysis:
Springview maintains a bullish stance on Mercury General despite recent wildfire-related losses, viewing the current weakness as a buying opportunity driven by investor overreaction. The manager's original thesis centered on California's improving regulatory environment and pricing dynamics, which played out successfully in 2024 with the company achieving normalized EPS above $10 per share. The Los Angeles wildfires created temporary uncertainty, but Springview's extensive due diligence concluded this represents an earnings event rather than a capital-threatening situation. The manager estimates normalized EPS of approximately $9.00 over the next few years, supporting significant upside from current levels. Paradoxically, the industry-wide $45 billion in catastrophe losses may strengthen the operating environment by tightening capacity and making regulators more receptive to rate increases. This should sustain favorable "hard market" conditions that support Mercury's profitability inflection. The investment thesis also includes potential M&A upside given the centenarian founder's age and possible succession planning.